State AZ
Clinical Trials in Arizona
Recruiting clinical trials with at least one study location in Arizona. Data updated daily from ClinicalTrials.gov.
Top Conditions in Arizona
NCT06184308 N/A
Recruiting
Improving Outcomes in PICS With Home-Based Program of Rehabilitation and Health ...
Condition
Post-Intensive Care Syndrome
Enrollment
220 pts
Location
United States
Sponsor
Mayo Clinic
NCT04831580 N/A
Recruiting
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Condition
Cervical Cancer
Enrollment
840 pts
Location
United States, Canada
Sponsor
GOG Foundation
NCT06481891 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obst...
Condition
Obstructive Cardiomyopathy, Hypertrophic
Enrollment
500 pts
Location
United States, Argentina, Belgium
Sponsor
Lexicon Pharmaceuticals
NCT05334069 N/A
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests...
Condition
Acute Lymphoblastic Leukemia
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT06324786 N/A
Recruiting
Brain Mechanisms of Reducing Polysubstance Use
Condition
Multiple Drug Use
Enrollment
35 pts
Location
United States
Sponsor
Arizona State University
NCT06095583 Phase 3
Recruiting
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consol...
Condition
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Enrollment
756 pts
Location
United States, Belgium, China
Sponsor
Shanghai Junshi Bioscience Co.
NCT06091254 Phase 3
Recruiting
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Work...
Condition
Follicular Lymphoma (FL)
Enrollment
822 pts
Location
United States, Australia, Austria
Sponsor
Regeneron Pharmaceuticals
NCT06613360 Phase 1
Recruiting
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, ...
Condition
SLE
Enrollment
24 pts
Location
United States, Australia, Bulgaria
Sponsor
Cullinan Therapeutics Inc.
NCT06395753 Phase 2
Recruiting
A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer
Condition
Prostate Cancer
Enrollment
66 pts
Location
United States, Belgium, France
Sponsor
Debiopharm International SA
NCT06029660 N/A
Recruiting
AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of...
Condition
Aortic Aneurysm, Abdominal
Enrollment
180 pts
Location
United States, France, Netherlands
Sponsor
Shape Memory Medical, Inc.
NCT05561127 Phase 3
Recruiting
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
Condition
Bowel; Stricture
Enrollment
171 pts
Location
United States
Sponsor
GIE Medical
NCT06045754 Phase 4
Recruiting
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Usteki...
Condition
Crohn's Disease
Enrollment
100 pts
Location
United States, Canada
Sponsor
Takeda
NCT06077942 N/A
Recruiting
FX Shoulder Solutions Retrospective / Prospective Clinical Study
Condition
Rotator Cuff Syndrome of Shoulder and Allied Disorders
Enrollment
600 pts
Location
United States
Sponsor
FX Shoulder Solutions
NCT04743141 Phase 3
Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatme...
Condition
Acute Treatment of Migraine
Enrollment
600 pts
Location
United States, Poland, Spain
Sponsor
Pfizer
NCT05785754 Phase 1
Recruiting
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastat...
Condition
Advanced or Metastatic Solid Tumors
Enrollment
320 pts
Location
United States, Australia, South Korea
Sponsor
DynamiCure Biotechnology
NCT06774131 Phase 3
Recruiting
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract...
Condition
Upper Urinary Tract Urothelial Carcinoma
Enrollment
70 pts
Location
United States, Bulgaria, Georgia
Sponsor
UroGen Pharma Ltd.
NCT06072482 Phase 4
Recruiting
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Condition
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Enrollment
300 pts
Location
United States, Czechia, Hungary
Sponsor
Amgen
NCT07219173 Phase 2
Recruiting
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With...
Condition
Asthma
Enrollment
531 pts
Location
United States, Argentina, Brazil
Sponsor
Eli Lilly and Company
NCT06752668 Phase 2
Recruiting
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Condition
Narcolepsy Type 1
Enrollment
96 pts
Location
United States, Canada
Sponsor
Centessa Pharmaceuticals (UK)
NCT06378866 Phase 2
Recruiting
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor ...
Condition
Recurrent Castration-Sensitive Prostate Carcinoma
Enrollment
532 pts
Location
United States
Sponsor
Mayo Clinic
NCT06356571 Phase 2
Recruiting
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfil...
Condition
Plasma Cell Myeloma Refractory
Enrollment
64 pts
Location
United States
Sponsor
Sanofi
NCT04870944 Phase 1, Phase 2
Recruiting
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS ...
Condition
Diffuse Midline Glioma, H3 K27-Altered
Enrollment
63 pts
Location
United States, Australia
Sponsor
Children's Oncology Group
NCT06410209 Phase 2
Recruiting
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervent...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
190 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
NCT06813911 Phase 3
Recruiting
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Partic...
Condition
Atherosclerotic Cardiovascular Disease (ASCVD)
Enrollment
340 pts
Location
United States, China, France
Sponsor
Novartis Pharmaceuticals
NCT07037433 Phase 3
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in P...
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
12,800 pts
Location
United States, Argentina, Australia
Sponsor
Amgen